skip to content
Primary navigation

Cosopt PF

Drug - Cosopt PF [Merck]

September 2012

Therapeutic area - Carbonic anhydrase inhibitors

Approval criteria

  • Patient has a diagnosis of ocular hypertension or open-angle glaucoma AND
  • Patient has tried and failed an ophthalmic beta-blocker AND
  • Patient has tried and failed Azopt or dorzolamide used in combination with timolol AND
  • Patient has a documented clinical need for a preservative free product


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top